SANOFICONR
Sanofi Consumer Healthcare India Limited (SANOFICONR) Stock Analysis
Sanofi Consumer Healthcare India Limited markets over-the-counter consumer health brands in pain relief, digestion, and wellness. It sells established brands through pharmacies and modern trade across India. The company focuses on self-care products for mass consumer markets. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - General
₹3,548.70
-0.92% 1W | -22.80% 52W
Market Cap
8.2k CR
P/E Ratio
30.7
52W High
₹5255
52W Low
₹3530.1
Div. Yield
2.1%
Beta
0.3
50 DMA
₹4078.4
200 DMA
₹4384
Profit Margin
28%
Inst. Own.
18.4%
📊 ANALYZING TREND
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 210 | 225 | 222 | 172 | 160 | 171 | 173 | 221 | 234 | 251 | 229 | 236 |
| Expenses | 116 | 135 | 140 | 109 | 97 | 109 | 109 | 151 | 149 | 161 | 140 | 146 |
| Operating Profit | 95 | 90 | 82 | 64 | 63 | 62 | 64 | 70 | 85 | 90 | 89 | 89 |
| OPM % | 45% | 40% | 37% | 37% | 39% | 36% | 37% | 32% | 36% | 36% | 39% | 38% |
| Other Income | 1 | 1 | 3 | -24 | 3 | 2 | 5 | 12 | 3 | 5 | 6 | 6 |
| Interest | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 95 | 90 | 84 | 39 | 61 | 63 | 67 | 79 | 84 | 90 | 91 | 92 |
| Tax % | 25% | 24% | 25% | 25% | 26% | 29% | 25% | 23% | 25% | 27% | 25% | 25% |
| Net Profit | 71 | 68 | 63 | 29 | 45 | 44 | 50 | 61 | 63 | 66 | 68 | 69 |
| EPS in Rs | 12.59 | 19.54 | 19.24 | 21.71 | 26.36 | 27.31 | 28.87 | 29.44 | 29.87 |
| Metric | Dec 20238m | Dec 2024 | Mar 2025 | Dec 2025 | TTM |
|---|---|---|---|---|---|
| Sales | 555 | 724 | 878 | 878 | 950 |
| Expenses | 337 | 454 | 569 | 569 | 597 |
| Operating Profit | 219 | 271 | 309 | 309 | 353 |
| OPM % | 39% | 37% | 35% | 35% | 37% |
| Other Income | 2 | -15 | 25 | 25 | 20 |
| Interest | 0 | 4 | 2 | 2 | 2 |
| Depreciation | 2 | 4 | 12 | 12 | 13 |
| Profit before tax | 219 | 247 | 320 | 320 | 357 |
| Tax % | 25% | 27% | 25% | 25% | |
| Net Profit | 165 | 181 | 240 | 240 | 266 |
| EPS in Rs | 78.59 | 104.25 | 104.25 | 115.49 | |
| Dividend Payout % | 6% | 70% | 0% | 72% |
Shareholding Pattern
Promoters71.27%
FIIs3.24%
DIIs16.89%
Public8.59%
Promoters71.27%
FIIs2.94%
DIIs17.21%
Public8.58%
Promoters71.27%
FIIs2.83%
DIIs17.33%
Public8.57%
Promoters71.27%
FIIs2.76%
DIIs17.57%
Public8.41%
Promoters71.27%
FIIs2.60%
DIIs17.85%
Public8.28%
Promoters60.40%
FIIs4.52%
DIIs25.48%
Public9.59%
Promoters71.27%
FIIs2.76%
DIIs17.57%
Public8.41%
Promoters71.27%
FIIs2.60%
DIIs17.85%
Public8.28%
SANOFICONR
Holdings Analysis
Key strengths & risk signals
69
Overall
94
Fundamental
45
Technical
Risks (3)
POOR YEAR! Stock declined 22.8% in the last year.
WEAK POSITION! Current price (3548.7) is below both moving averages.
WEAK! Trading at 1.1% of 52W range - near yearly lows.
Strengths (3)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
OVERSOLD! RSI at 20.7 - potential bounce opportunity.
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
Fundamental & Technical Analysis
69Overall
94Fundamental
45Technical
Fundamental Breakdown
Growth Quality
30/30
Revenue CAGR: 27.0% (EXCELLENT, 15/15). Profit CAGR: 20.7% (EXCELLENT, 15/15).
Profit Margin
9/10
EXCELLENT EFFICIENCY! 28.0% profit margin - company keeps strong profits.
PEG Valuation
9/10
FAIRLY VALUED! PEG of 1.48 indicates reasonable valuation.
Dividend Yield
6/10
MODERATE DIVIDEND! 2.1% yield - some income benefit.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.11 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 10.98% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (4078.4) is below 200-day average (4384.0) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (3548.7) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
1/10
POOR YEAR! Stock declined 22.8% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 8 up days, 22 down days. Avg volume on up days: 5,446 vs down days: 6,412. Ratio: 0.85x
RSI
5/5
OVERSOLD! RSI at 20.7 - potential bounce opportunity.
52W Range
1/5
WEAK! Trading at 1.1% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 0.9% (1 week), 11.1% (1 month), 22.3% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
SANOFICONR
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q3FY262026-03-27 | Concall PDF |
Peer Comparison
Healthcare · Drug Manufacturers - General · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SANOFICONR | ₹3,548.70 | 30.7 | 28.0% | 27.0% | 20.7% | -22.8% | 69 | BREAKDOWN | +13.3% | +1.5% | +6.7% | +2.8% |
| SANOFI | ₹2,942.10 | 20.9 | 17.9% | -12.6% | -19.3% | -36.8% | 57 | APPROACHING SUPPORT | +20.1% | -18.6% | +7.7% | -7.3% |
| SENORES | ₹1,318.40 | 46.4 | 18.7% | 159.1% | 139.2% | +79.3% | 77 | APPROACHING RESISTANCE | +55.8% | -2.8% | +35.9% | +2.9% |
| MARKSANS | ₹311.00 | 27.3 | 16.3% | 16.7% | 16.2% | +73.9% | 70 | BREAKDOWN | +169.6% | +6.1% | +35.6% | -1.8% |
| PFIZER | ₹3,814.00 | 23.7 | 28.6% | 1.3% | 5.0% | -28.4% | 51 | BREAKOUT | +6.6% | +2.4% | +8.3% | +3.8% |
| SMSPHARMA | ₹450.50 | 40.1 | 11.4% | 19.3% | – | +44.6% | 74 | BREAKDOWN | +2.0% | -36.1% | +5.6% | -13.0% |
| SAIPARENT | ₹487.30 | 168 | 3.9% | 126.1% | 111.8% | +19.3% | 67 | APPROACHING RESISTANCE | +464.3% | -1,416.7% | +435.0% | -33.6% |
| NGLFINE | ₹2,784.60 | 30.1 | 10.7% | 21.8% | 32.9% | +89.0% | 79 | APPROACHING SUPPORT | +100.0% | +36.3% | +33.6% | -6.7% |
Data from TradeAlone · Updated daily
No news tagged for SANOFICONR yet.
